HOME >> MEDICINE >> NEWS
Possible Mechanism For Estrogen Memory Enhancement Found

University of Southern California neuroscientists have found a chemical mechanism that explains how estrogen enhances the process believed responsible for memory.

"Previous studies have suggested that the hormone estrogen delays the onset of Alzheimer's disease, and several million post-menopausal women are taking estrogen supplements for that reason," says USC neurophysiologist Richard F. Thompson, Ph.D. "Our research reveals a chemical mechanism that could explain how the delay in onset occurs."

Dr. Thompson and his colleagues measured the excitability and long-term potentiation between neurons from the brain of a rat, both before and after exposing slices of the brain's hippocampus to estrogen. The researchers looked specifically at the hormone's influence on a neurotransmitter called glutamate and two of its receptors, NMDA and AMPA. Neurotransmitters are chemicals that mediate the transmission of electrical impulses across the synapses between neurons.

"The estrogen activated both receptors within minutes -- causing a lasting increase in neuronal activity," Thompson reports. "Estrogen also enhanced the process of long-term potentiation. Activating the NMDA receptor apparently initiates long-term potentiation, and the AMPA receptors maintain it."

Since its discovery more than two decades ago, long-term potentiation has been intensively studied in hundreds of research laboratories around the world. The phenomenon is a long-lasting increase in neuronal responses in the hippocampus, a major structure in the forebrain of all mammals. It is thought to be a mechanism of memory shortage in the brain.

Thompson believes that learning more about the mechanism of long-term potentiation could lead to highly refined treatments for Alzheimer's disease. Researchers are studying compounds that are similar or related to estrogen in the hope of finding a drug precisely targeted for the treatment of disease while avoiding unwanted side-effects.

USC neur
'"/>

Contact: Bob Calverley
calverle@usc.edu
213-740-4750
University of Southern California
17-Mar-1999


Page: 1 2

Related medicine news :

1. Mayo Clinic researchers restore lost immunity -- Possible breakthrough for AIDS
2. Possible brain cancer-air pollution link to be studied
3. Possible new cancer therapy shrinks tumors in melanoma patients, Science authors report
4. Possible outpatient relief for millions of older men: MD researcher develops improved technology to shrink enlarged prostate glands without surgery
5. Possible link between heart attack and helicobacter pylori infection
6. UI Researchers Identify Possible Reason For Rare, Accelerated Aging Condition
7. New Procedure Makes A Successful Transplant Possible
8. Future Chlamydia Screening Should Take Account Of Possible Disadvantages For Women
9. UF Researchers Cite Possible Link Between Autism, Schizophrenia And Diet
10. More Evidence Of Possible Adverse Effects From New Hormone Use In Women With Heart Disease
11. Commercial Scale Cultivation Of Pharmaceutical-Producing Tobacco Possible, Virginia Tech Scientists Find

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Possible Mechanism For Estrogen Memory Enhancement Found

(Date:8/4/2015)... ... August 04, 2015 , ... In ... filed against Johnson & Johnson report that a new location for pretrial proceedings ... regular news updates and cancer warning information at their website, the Talcum Powder ...
(Date:8/4/2015)... ... August 04, 2015 , ... Nathan’s Famous was recently ... small, medium, and large businesses making an impact in their industry. Andrew Tropeano, the ... how the famous hot dog maker now offers a 50% Reduced Fat All-Beef ...
(Date:8/4/2015)... Palm Coast, Florida (PRWEB) , ... August 04, ... ... Daiichi Sankyo Inc have awarded independent educational grants in support of an interaction ... Prevention and DVT/PE." The activity is jointly provided by Medical Learning Institute Inc. ...
(Date:8/4/2015)... ... August 04, 2015 , ... Please join us for the ... Sunday, September 20th at Oneida Shores Park in Brewerton, NY. , Doris Connor ... brain aneurysm at the young age of 59. Her family and friends have since ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... a state-of-the-art digital press at its Denver facility that will usher in a ... will help Lightning Labels more effectively meet its twin objectives of ...
Breaking Medicine News(10 mins):Health News:Talcum Powder Lawsuits: Plaintiffs Suggest Middlesex County Transfer 2Health News:Talcum Powder Lawsuits: Plaintiffs Suggest Middlesex County Transfer 3Health News:Talcum Powder Lawsuits: Plaintiffs Suggest Middlesex County Transfer 4Health News:Celebrate Summer with Nathan’s Famous Original Selfie Sweepstakes 2Health News:Celebrate Summer with Nathan’s Famous Original Selfie Sweepstakes 3Health News:Innovative Medical Interactive Simulation Session to be presented at upcoming Continuing Education Company Education (CME) Conferences. 2Health News:Innovative Medical Interactive Simulation Session to be presented at upcoming Continuing Education Company Education (CME) Conferences. 3Health News:4th Annual Doris A. Connor Memorial Event for Brain Aneurysm Awareness to be Held in Brewerton, NY with Proceeds Benefitting Renowned Brain Aneurysm Foundation 2Health News:4th Annual Doris A. Connor Memorial Event for Brain Aneurysm Awareness to be Held in Brewerton, NY with Proceeds Benefitting Renowned Brain Aneurysm Foundation 3Health News:Lightning Labels Installs State-of-the-Art Digital Press 2Health News:Lightning Labels Installs State-of-the-Art Digital Press 3
(Date:8/3/2015)... 3, 2015  CytRx Corporation (NASDAQ: CYTR ), ... today reported financial results for the three months ended ... recent accomplishments and upcoming milestones for its clinical development ... been very productive for CytRx. Enrollment in our ongoing ... soft tissue sarcoma (STS) continues on track to be ...
(Date:8/3/2015)... Colo., Aug. 3, 2015  Array BioPharma Inc. ... the fourth quarter and full year of its ... Ron Squarer, Chief Executive Officer of Array, noted, "Binimetinib ... 3, are on track for regulatory submissions in ... BRAF-mutant melanoma and BRAF-mutant colorectal cancer further validate ...
(Date:8/3/2015)... 2015 Immune Pharmaceuticals, Inc. ("Immune") (NASDAQ: ... Teper , will present live at VirtualInvestorConferences.com on August ...   11:30AM EDT LINK:    http://tinyurl.com/aug6-pre-imnp ... where investors are invited to ask the company questions ... well as the association,s "virtual trade booth." If attendees ...
Breaking Medicine Technology:CytRx Reports 2015 Second Quarter Financial Results 2CytRx Reports 2015 Second Quarter Financial Results 3CytRx Reports 2015 Second Quarter Financial Results 4CytRx Reports 2015 Second Quarter Financial Results 5CytRx Reports 2015 Second Quarter Financial Results 6CytRx Reports 2015 Second Quarter Financial Results 7CytRx Reports 2015 Second Quarter Financial Results 8CytRx Reports 2015 Second Quarter Financial Results 9CytRx Reports 2015 Second Quarter Financial Results 10CytRx Reports 2015 Second Quarter Financial Results 11CytRx Reports 2015 Second Quarter Financial Results 12CytRx Reports 2015 Second Quarter Financial Results 13CytRx Reports 2015 Second Quarter Financial Results 14Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 2Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 3Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 4Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 5Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 6Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 7Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 8Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 9Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 10Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 11Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 12Immune Pharmaceuticals to Webcast Live at VirtualInvestorConferences.com August 6 2
Cached News: